Al-zahra university hospital
Isfahan, Iran
NCT Number: NCT01273831
The purpose of this study is to determine which drug makes lower intraocular pressure
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2
Isfahan, Iran
Increase in intraocular pressure (IOP) following tracheal intubation during general anesthesia can be troublesome. The investigators compared the influence of cisatracurium and atracurium on IOP in patients undergoing general anesthesia.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
ASA class of I or II baseline IOP of lower than 20 mmHg stable hemodynamics no history of ophthalmic diseases not using drugs affecting IOP (e.g. anticholinergics, sympathomimetics) no contraindication for atracurium or cisatracurium administration.
Exclusion criteria
difficulty in mask ventilation or in tracheal intubation end expiratory CO2 of below 35 mmHg or over 45 mmHg O2 saturation of below 90%
atracurium, Drop,0.5 mg/kg, one time, one day
cisatracurium, drop,0.15mg/kg,one time, one day
Time frame: at 2 minutes after intubation
determining intraocular pressure in atracurium and cisatracurium groups
Time frame: at 2 minutes after intubation
identification of systolic blood pressure in atracurium and cisatracurium groups
Isfahan University of Medical Sciences
Other
Study of Effects of Cisatracurium and Atracurium on Intraocular Pressure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04281017
Intraocular Pressure, Neoplasms
Gainesville, Florida, United States
View Trial DetailsNCT07274176
Intraocular Pressure
Uşak, Turkey (Türkiye)
View Trial DetailsNCT07701278
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Banhā, Benha, Egypt
View Trial DetailsNCT07604428
Apnea, Eye Diseases
Olomouc, Czechia
View Trial Details